Table 1.
Age | Gender | Diabetes | Ethnicity | Cause of death | Application | Time elapsed before culture (h) | Eye complication Status | Diabetes status and other diagnosis |
---|---|---|---|---|---|---|---|---|
64 | Male | YES | Unknown | Heart failure | Retina and retina EVs proteomic analysis and WB | 32 | Diabetic Retinopathy | DM Type I |
63 | Male | YES | Unknown | Renal failure | Retina and retina EVs proteomic analysis and WB | 24 | Diabetic Retinopathy | DM Type I |
54 | Male | YES | Hispanic | Coronary Artery Disease | Retina EVs isolation for NTA, Uptake and TEM | 22 | No Diabetic Retinopathy | Morbidly obese. DM Type II |
73 | Male | YES | Caucasian | Hypoglicemia | Retina EVs isolation for NTA, Uptake and WB | 21 | Diabetic Retinopathy | Cataracts, Possible Glaucoma |
71 | Male | YES | Unknown | Pancreatic cancer | Retina EVs isolation for NTA | 24 | Diabetic Retinopathy | Cataracts |
68 | Male | YES | Hispanic | unknown | Retina EVs isolation for NTA and WB | 16 | No Diabetic Retinopathy | Cataracts, Lasik |
68 | Male | YES | Hispanic | Cardiopulmonary collapse | Retina EVs isolation for NTA and WB | 15 | No Diabetic Retinopathy | Cataracts, Lasik |
66 | Female | YES | Hispanic | unknown | Retina EVs isolation for NTA and WB | 22 | Diabetic Retinopathy | Cataracts, Lasik |
59 | Male | YES | Caucasian | Heart disease | Retina EVs isolation for NTA and WB | 24 | No Diabetic Retinopathy | Hydrocephalus |
65,1 ± 5,9 | 22,2 ± 4,9 | |||||||
62 | Male | NO | Unknown | Heart failure | Retina and retina EVs proteomic analysis and WB | 26 | Non Diabetic - No DR | Metastatic cancer |
56 | Male | NO | Unknown | Unknown | Retina and retina EVs proteomic analysis and WB | 13 | Non Diabetic - No DR | None |
26 | Male | NO | Caucasian | Heart failure | Retina EVs isolation for NTA and qPCR | 40 | Non Diabetic - No DR | Drug overdose. No ocular history |
27 | Male | NO | Unknown | Cholangiocarcinoma stage IV | Retina EVs isolation for WB | 12 | Non Diabetic - No DR | Artificial tears |
35 | Male | NO | Causcasian | Endocarditis | Retina EVs isolation for NTA and WB | 44 | Non Diabetic - No DR | None |
21 | Male | NO | Caucasian | Lupus | Retina EVs isolation for NTA and WB | 20 | Non Diabetic - No DR | None |
32 | Male | NO | Caucasian | Sheptic shock | Retina EVs isolation for NTA | 29 | Non Diabetic - No DR | None |
63 | Male | NO | Hispanic | Cardiopulmonary Arrest | Retina EVs isolation for NTA | 25 | Non Diabetic - No DR | Colorectal cancer |
31 | Male | NO | Caucasian | Endstage Liver disease | Retina EVs isolation for NTA | 48 | Non Diabetic - No DR | None |
61 | Female | NO | Caucasian | Amyotrophic lateral sclerosis | Retina EVs isolation for NTA | 36 | Non Diabetic - No DR | None |
52 | Female | NO | Caucasian | Cerebrovascular/Stroke | Retina EVs isolation for NTA | 87 | Non Diabetic - No DR | None |
39,1 ± 16,2 | 37,8 ± 21,7 |
Average ± standard dev. Included below age and time elapsed columns. EVs, Extracellular vesicles; WB, Western Blot; NTA, Nanoparticle tracking analysis; TEM, Transmission electron microscopy; DM, Diabetes Mellitus; DR, Diabetic Retinopathy.